InvestorsHub Logo
Followers 88
Posts 25965
Boards Moderated 1
Alias Born 03/26/2014

Re: None

Wednesday, 04/17/2019 7:51:56 PM

Wednesday, April 17, 2019 7:51:56 PM

Post# of 400693
Let's do the Math For ELTP Shall We

850 Million Shares Outstanding.

Let's call it 1 Billion Shares Outstanding for Simplicity.

Each $10 Million in profit is $.01 earnings per share.

Now assign a multiple or a PE. Current PE averages for companies are between 20--25

BUT

High Growth Companies get High PE's

ELTP will be a High Growth Company.

$10 Million in Profit.

Each $.01 in earning X PE 30, 60 = $.30 or $.60

$30 Million in Profit or $.03 X PE 30, 60 = $.90 or $1.80.

Isradipine is a $500 Million Market if it Works.

Think Isradipine can product profit of $30 Million or more for ELTP? I do.

Now the above example applies to the $4 Billion in Generic Drugs ELTP has entered.

My Conclusion --- Massive Gains Next two years and into the future with or without Isradipine.

Isradipine is Elite's FREE WILDCARD!!

Another CLUE: It Would NOT be Unreasonable for ELTP

to Get a Very High PE in Anticipation of Fast High Growth.

100+ PE Can Happen.

I Specialize in the Removal of Cockroaches, Jackals, Vultures and Wolves.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News